Center for Reproductive Medicine, Amsterdam UMC, Amsterdam Reproduction and Development Research Institute, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.
Karolinska Institutet, Karolinska University Hospital, NORDFERTIL Research Lab Stockholm, Childhood Cancer Research Unit, Department of Women's and Children's Health, Visionsgatan 4, SE-17164, Solna, Sweden.
Dev Biol. 2019 Dec 1;456(1):25-30. doi: 10.1016/j.ydbio.2019.08.007. Epub 2019 Aug 14.
The current strategy to preserve fertility of male prepubertal cancer patients consists of cryopreservation of a testicular tissue biopsy containing spermatogonial stem cells (SSCs). While in humans, fertility restoration strategies from prepubertal testicular tissues are still under investigation and have not yet resulted in complete germ cell differentiation, in mice various studies have described production of sperm and offspring through testicular organ culture and transplantation of in vitro propagated SSCs. Organ culture has shown to be successful in generating mature spermatozoa when using testicular fragments from various mouse strains, including CD1 and C57BL/6 J. Conversely, in vitro proliferation of SSCs from C57BL/6 J mice is highly inefficient when compared to other strains such as DBA2 or hybrid mice of C57BL/6 J and DBA2 with 75% C57BL/6 J background (B6D2F2). In this study, we investigated in vitro spermatogenesis by organ culture using testicular tissue from C57BL/6 J and B6D2F2 mice. Whereas spermatogenesis was initiated and completed in C57BL/6 J fragments, it could not be effectively supported in B6D2F2 testicular tissue. While maturation of Sertoli cells and Leydig cells functionality appeared to be identical between the two strains, in B6D2F2 tissue spermatogenesis did not proceed past the spermatocyte step, followed by a rapid decline of the number of all germ cells in the fragments. This suggests that the spermatogenic potential in vitro is dependent on specialized sites in the genome and therefore the organ culture conditions suboptimal for some strains of mice.
目前,保护青春期前癌症男性患者生育能力的策略包括冷冻保存含有精原干细胞(SSC)的睾丸组织活检。虽然在人类中,从青春期前的睾丸组织恢复生育力的策略仍在研究中,尚未导致完全的生殖细胞分化,但在小鼠中,各种研究已经描述了通过睾丸器官培养和体外增殖的 SSC 移植来产生精子和后代。器官培养已被证明在使用来自各种小鼠品系(包括 CD1 和 C57BL/6J)的睾丸片段时成功产生成熟的精子,相反,与其他品系(如 DBA2 或 C57BL/6J 和 DBA2 的杂交鼠,具有 75%的 C57BL/6J 背景(B6D2F2))相比,C57BL/6J 小鼠的 SSC 体外增殖效率非常低。在这项研究中,我们使用 C57BL/6J 和 B6D2F2 小鼠的睾丸组织研究了体外精子发生的器官培养。虽然 C57BL/6J 片段中启动并完成了精子发生,但 B6D2F2 睾丸组织中不能有效地支持。虽然 Sertoli 细胞和 Leydig 细胞功能的成熟似乎在两个品系之间相同,但在 B6D2F2 组织中,精子发生不能有效地进行,不能进入精子细胞阶段,随后片段中所有生殖细胞的数量迅速下降。这表明体外的精子发生潜能取决于基因组中的特殊部位,因此,对于某些小鼠品系,器官培养条件并不理想。